Articles with public access mandates - Francesco (Francis) CosentinoLearn more
Available somewhere: 15
The PD‐1 pathway in tolerance and autoimmunity
LM Francisco, PT Sage, AH Sharpe
Immunological reviews 236 (1), 219-242, 2010
Mandates: US National Institutes of Health
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
LM Francisco, VH Salinas, KE Brown, VK Vanguri, GJ Freeman, ...
Journal of Experimental Medicine 206 (13), 3015-3029, 2009
Mandates: US National Institutes of Health
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF
M Quigley, F Pereyra, B Nilsson, F Porichis, C Fonseca, Q Eichbaum, ...
Nature medicine 16 (10), 1147-1151, 2010
Mandates: US National Institutes of Health
The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood
PT Sage, LM Francisco, CV Carman, AH Sharpe
Nature immunology 14 (2), 152-161, 2013
Mandates: US National Institutes of Health
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
Y Xiao, S Yu, B Zhu, D Bedoret, X Bu, LM Francisco, P Hua, ...
Journal of Experimental Medicine 211 (5), 943-959, 2014
Mandates: US National Institutes of Health
Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1
K Hirahara, K Ghoreschi, XP Yang, H Takahashi, A Laurence, G Vahedi, ...
Immunity 36 (6), 1017-1030, 2012
Mandates: US National Institutes of Health
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance
CL Tan, JR Kuchroo, PT Sage, D Liang, LM Francisco, J Buck, YR Thaker, ...
Journal of Experimental Medicine 218 (1), 2021
Mandates: US National Science Foundation, US National Institutes of Health
The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
MD Sharma, R Shinde, TL McGaha, L Huang, RB Holmgaard, ...
Science advances 1 (10), e1500845, 2015
Mandates: US National Institutes of Health
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade
ED Reynoso, KG Elpek, L Francisco, R Bronson, A Bellemare-Pelletier, ...
The Journal of Immunology 182 (4), 2102-2112, 2009
Mandates: US National Institutes of Health
The PD-1 pathway regulates development and function of memory CD8+ T cells following respiratory viral infection
KE Pauken, J Godec, PM Odorizzi, KE Brown, KB Yates, SF Ngiow, ...
Cell reports 31 (13), 2020
Mandates: US National Institutes of Health, Cancer Research Institute, USA
Physiologic control of IDO competence in splenic dendritic cells
B Baban, PR Chandler, BA Johnson, L Huang, M Li, ML Sharpe, ...
The Journal of Immunology 187 (5), 2329-2335, 2011
Mandates: US National Institutes of Health
B7‐1/2, but not PD‐L1/2 molecules, are required on IL‐10‐treated tolerogenic DC and DC‐derived exosomes for in vivo function
MA Ruffner, SH Kim, NR Bianco, LM Francisco, AH Sharpe, PD Robbins
European journal of immunology 39 (11), 3084-3090, 2009
Mandates: US National Institutes of Health
Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells
L Chen, CW Sham, AM Chan, LM Francisco, Y Wu, S Mareninov, ...
Investigative ophthalmology & visual science 50 (10), 4941-4948, 2009
Mandates: US National Institutes of Health
Neuronal programmed cell death-1 ligand expression regulates retinal ganglion cell number in neonatal and adult mice
CW Sham, AM Chan, JMK Kwong, J Caprioli, S Nusinowitz, B Chen, ...
Journal of Neuro-Ophthalmology 32 (3), 227-237, 2012
Mandates: US National Institutes of Health
PD-1 controls lymph node and blood T follicular regulatory cells
PT Sage, LM Francisco, CV Carman, AH Sharpe
Nature immunology 14 (2), 152, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program